SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization - PubMed (original) (raw)
. 2015 Jul;34(27):3582-92.
doi: 10.1038/onc.2014.289. Epub 2014 Sep 15.
Affiliations
- PMID: 25220418
- DOI: 10.1038/onc.2014.289
SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization
B K A Seong et al. Oncogene. 2015 Jul.
Abstract
Osteosarcoma (OS) is the most common malignant bone tumor and the majority of recurrences are due to metastasis. However, the molecular mechanisms that regulate OS metastatic spread are largely unknown. In this study, we report that special AT-rich-binding protein 2 (SATB2) is highly expressed in OS cells and tumors. Short hairpin RNA-mediated knockdown of SATB2 (sh-SATB2) decreases migration and invasion of OS cells without affecting proliferation or viability. Microarray analysis identified genes that were differentially regulated by SATB2 including the actin-binding protein Epithelial Protein Lost In Neoplasm (EPLIN), which was upregulated in sh-SATB2 cells. Silencing EPLIN rescues the decreased invasion observed in sh-SATB2 cells. Pathway analyses of SATB2-regulated genes revealed enrichment of those involved in cytoskeleton dynamics, and increased stress fiber formation was detected in cells with SATB2 knockdown. Furthermore, sh-SATB2 cells exhibit increased RhoA, decreased Rac1 and increased phosphorylation of focal adhesion kinase (FAK) and paxillin. These findings identify SATB2 as a novel regulator of OS invasion, in part via effects on EPLIN and the cytoskeleton.
Similar articles
- Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.
Xu HY, Fang W, Huang ZW, Lu JC, Wang YQ, Tang QL, Song GH, Kang Y, Zhu XJ, Zou CY, Yang HL, Shen JN, Wang J. Xu HY, et al. Eur Rev Med Pharmacol Sci. 2017 Oct;21(20):4516-4528. Eur Rev Med Pharmacol Sci. 2017. PMID: 29131265 - A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth.
Liu SH, Zhu JW, Xu HH, Zhang GQ, Wang Y, Liu YM, Liang JB, Wang YX, Wu Y, Guo QF. Liu SH, et al. Mol Cell Biochem. 2017 Jun;430(1-2):47-56. doi: 10.1007/s11010-017-2953-9. Epub 2017 Feb 11. Mol Cell Biochem. 2017. PMID: 28190168 - Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P, Helman L. Khanna C, et al. Cancer Res. 2001 May 1;61(9):3750-9. Cancer Res. 2001. PMID: 11325848 - Proteomics and genomics insights on malignant osteosarcoma.
Kathiresan N, Selvaraj C, Pandian S, Subbaraj GK, Alothaim AS, Safi SZ, Kulathaivel L. Kathiresan N, et al. Adv Protein Chem Struct Biol. 2024;138:275-300. doi: 10.1016/bs.apcsb.2023.06.001. Epub 2023 Nov 28. Adv Protein Chem Struct Biol. 2024. PMID: 38220428 Review. - EPLIN: a fundamental actin regulator in cancer metastasis?
Collins RJ, Jiang WG, Hargest R, Mason MD, Sanders AJ. Collins RJ, et al. Cancer Metastasis Rev. 2015 Dec;34(4):753-64. doi: 10.1007/s10555-015-9595-8. Cancer Metastasis Rev. 2015. PMID: 26350886 Free PMC article. Review.
Cited by
- Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma.
Ladumor Y, Seong BKA, Hallett R, Valencia-Sama I, Adderley T, Wang Y, Kee L, Gont A, Kaplan DR, Irwin MS. Ladumor Y, et al. Mol Cancer Res. 2022 Jun 3;20(6):895-908. doi: 10.1158/1541-7786.MCR-21-0425. Mol Cancer Res. 2022. PMID: 35190818 Free PMC article. - BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.
Wang S, Ren T, Jiao G, Huang Y, Bao X, Zhang F, Liu K, Zheng B, Sun K, Guo W. Wang S, et al. Oncotarget. 2017 Apr 24;8(35):58625-58641. doi: 10.18632/oncotarget.17382. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938584 Free PMC article. - SATB2 suppresses gastric cancer cell proliferation and migration.
Wu L, Chen J, Qin Y, Mo X, Huang M, Ru H, Yang Y, Liu J, Lin Y. Wu L, et al. Tumour Biol. 2016 Apr;37(4):4597-602. doi: 10.1007/s13277-015-4282-5. Epub 2015 Oct 27. Tumour Biol. 2016. PMID: 26508023 - Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.
Chang CY, Shipony Z, Lin SG, Kuo A, Xiong X, Loh KM, Greenleaf WJ, Crabtree GR. Chang CY, et al. Mol Cell. 2021 Dec 16;81(24):4964-4978.e8. doi: 10.1016/j.molcel.2021.10.005. Epub 2021 Oct 22. Mol Cell. 2021. PMID: 34687603 Free PMC article. - Role of miR-31 and SATB2 in arsenic-induced malignant BEAS-2B cell transformation.
Chen QY, Li J, Sun H, Wu F, Zhu Y, Kluz T, Jordan A, DesMarais T, Zhang X, Murphy A, Costa M. Chen QY, et al. Mol Carcinog. 2018 Aug;57(8):968-977. doi: 10.1002/mc.22817. Epub 2018 Apr 17. Mol Carcinog. 2018. PMID: 29603397 Free PMC article.
References
- J Cell Biol. 2003 Feb 3;160(3):399-407 - PubMed
- Cancer Res. 2012 Apr 1;72(7):1865-77 - PubMed
- Neuron. 2008 Feb 7;57(3):378-92 - PubMed
- PLoS One. 2010 Nov 15;5(11):e13984 - PubMed
- Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19879-84 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous